世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

経皮薬物送達システム市場規模および予測（2020年～2030年）、世界および地域シェア、動向、成長機会分析レポート対象範囲タイプ別（経皮パッチ、経皮ゲル、経皮スプレー、その他）、用途別（心血管疾患、中枢神経系疾患、疼痛管理、ホルモン用途、その他）、流通チャネル別（病院薬局、小売薬局、オンライン薬局、その他）


Transdermal Drug Delivery System Market Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Type (Transdermal Patches, Transdermal Gel, Transdermal Sprays, and Others), Application (Cardiovascular Diseases, Central Nervous System Disorders, Pain Management, Hormonal Applications, and Other Applications), and Distribution Channel (Hospitals Pharmacies, Retail Pharmacies, Online Pharmacies, and Others)

経皮薬物送達システムの世界市場は、2022年の372億3,000万米ドルから2030年には519億4,900万米ドルに達すると予測されている。2022年から2030年までの年平均成長率は4.3%と推定される。 市場の成長を促す主な... もっと見る

　

　

出版社 出版年月 電子版価格 ページ数 言語
The Insight Partners
ザ・インサイトパートナーズ 		2023年10月23日 US$4,550
シングルユーザライセンス
ライセンス・価格情報
注文方法はこちら 		233 英語

日本語のページは自動翻訳を利用し作成しています。
実際のレポートは英文のみでご納品いたします。


　

サマリー

経皮薬物送達システムの世界市場は、2022年の372億3,000万米ドルから2030年には519億4,900万米ドルに達すると予測されている。2022年から2030年までの年平均成長率は4.3%と推定される。

市場の成長を促す主な要因としては、経皮薬物送達システムの応用分野の拡大、脊髄損傷事例の増加などが挙げられる。しかし、術後の合併症が市場成長の妨げとなっている。

経皮薬物送達システム市場の市場機会

経皮薬物投与ルートは新規性があり、持続的な薬物送達の信頼できる手段の一つである。この分野で重要な研究が行われ、この薬物送達形態に対する研究者の関心が高まっていることから、今後、多数の経皮パッチが市場に出回る可能性が高い。経皮パッチは、ニコチン、フェンタニル、ニトログリセリン、クロニジンなどの薬物を送達し、さまざまな病状を治療するために使用される。最近では、これらのパッチは、様々な用途で生物製剤を送達するために研究されている。スマート・パッチは、患者の状態をモニターし、それに応じて薬物送達を調整するためのセンサーやその他の技術を備えている。2023年1月、スウォンジー大学の主任科学者は、マイクロニードル技術を用いてパーキンソン病やアルツハイマー病などの神経変性疾患の炎症性バイオマーカーを検出する新しいスマートパッチを開発した。このスマートパッチは、低侵襲で皮膚バリアを貫通するように設計された多数のマイクロニードルで構成され、その後、臨床的に重要なバイオマーカーをモニタリングする。一般診療所や自宅でのポイントオブケア診断のために自己投与することができる。この革新的な研究は、神経変性疾患の早期発見のあり方を変える可能性がある。

皮膚外用3Dプリント製品：2021年11月にNational Library of Medicineに掲載された「From Personalized Dressings to Drug Delivery」によると、皮膚表面に適合するパーソナライズされた3Dプリントパッチは、アセチルヘキサペプチド3（AHP-3）の送達に使用できる。この研究では、ポリエチレングリコールジアクリレート（PEGDA）とビニルピロリドン（VP）という2種類の液体モノマーを異なる割合で使用し、最終ポリマーの機械的強度、重合速度、膨潤速度を改善した。樹脂への最適な薬物担持により、AHP-3は製造工程を通じて安定であり、最終ポリマーの物性に影響を及ぼさないことが示された。3Dスキャンされた顔面モデルを用いて、パーソナライズされたパッチがコンピュータ支援設計ソフトウェアで設計され、デジタル光加工3Dプリンタを用いて最適化された樹脂で作製された。調製された経皮パッチのin-vitro特性評価により、ヒトの死体皮膚に浸透する能力が示され、さらに圧縮しても無傷のままであることが確認された。「皮膚外用3Dプリント製品：パーソナライズド・ドレッシングからドラッグ・デリバリーまで "は、フォトポリマーを用いたパーソナライズド・パッチを実証した最初の研究であり、効果的なシワ管理のための薬剤の経皮デリバリーを改善する新しいアプローチを紹介した。

このように、3Dプリンティング技術とスマートパッチの採用は、今後数年間、経皮薬物送達システム市場に機会を提供する可能性が高い。

経皮薬物送達システム市場を阻害する要因

現在販売されている経皮ドラッグデリバリーシステム（TDDS）、経粘膜ドラッグデリバリーシステム（TMDS）、局所用パッチは、意図した使用期間終了後、最初の薬剤総量の10～95%が残留薬剤として残る可能性がある。このことは、患者やその家族、介護者にとって潜在的な安全性の問題を引き起こす。例えば、患者が意図した使用期間の終了時にTDDSを除去しなかったことによる有害事象は、一般に薬物の薬理作用の増大または延長をもたらす。また、廃棄されたTDDSに誤って曝露して死亡した小児も報告されている。以下は、メーカーによる製品の回収および撤去の一部である。

2023年2月、Aveva Drug Delivery Systems Inc.は、ブプレノルフィン経皮吸収システムの2ロットを、不純物／分解仕様を満たしていないとして回収した。Aveva Drug Delivery Systems社は2023年2月15日に自主的にリコールを開始し、2023年3月14日にFDAによりクラスIIIリコールに指定された。このリコール分類では、製品の使用が重大な危害を引き起こす可能性はないとされている。2020年9月、Teva Pharmaceuticals USA社は2ロットのブプレノルフィンパッチをリコールした。リコールの対象となったのは、ロット 190017 および 190161 のブプレノルフィン経皮吸収システム（パッチ NDC 0093-3656-21、カートン NDC 0093-3656-40）1 カートンあたり 4 枚、1 時間あたり 5 mcg、32,543 カートンである。この製品は3M Drug Delivery Systems社がTeva Pharmaceuticals社のために製造し、米国およびプエルトリコで販売されていた。Teva Pharmaceuticals社による2020年9月4日の自主回収に続き、FDAは2020年10月1日にリコールをクラスⅡに指定した。クラスⅡのリコール製品の使用を継続すると、一時的または医学的に可逆的な健康上の悪影響が生じる可能性がある。遠隔ではあるが、重大な危害の可能性が存在する。さらに2018年4月、FDAはPhase 4 Pharmaceutical LLCに警告書を送付した。同社は経皮吸収型製剤を製造するのではなく、一般用医薬品（OTC）の経皮吸収型製剤の再包装業者として機能しており、FDAは製品の品質に影響を及ぼす複数のCGMP違反を発見した。2019年4月、Alvogen, Inc.は、ラベルの取り違えを理由に、フェンタニル経皮システム、12 mcg/h経皮パッチの2ロット（またはバッチ）の全国自主回収を発表した。このように、経皮吸収型製剤の副作用や回収は市場成長の妨げとなっている。

経皮薬物送達システム市場：セグメント別概要

経皮ドラッグデリバリーシステム市場は、製品別に、経皮パッチ、経皮ゲル、経皮スプレー、その他に区分される。経皮パッチセグメントはさらに、薬物接着パッチ、リザーバー膜パッチ、マトリックスパッチ、蒸気パッチにセグメント化される。経皮パッチセグメントは2022年に市場で最大のシェアを占め、経皮ゲルは2022-2030年に最も高いCAGRを記録すると予測されている。経皮パッチは、患者の皮膚に貼付し、皮膚を通して薬物を送達する薬物送達システムである。

経皮薬物送達システム市場は、用途別に心血管疾患、中枢神経系疾患、ホルモン用途、疼痛管理、その他の用途に区分されている。疼痛管理分野は、オピオイド用途と非オピオイド用途に細分化される。ホルモン用途市場は、さらに経皮エストロゲン療法とテストステロン補充療法に区分される。疼痛管理分野が2022年の市場で最大のシェアを占めている。中枢神経系疾患セグメントは、2022〜2030年の間に市場で最も高いCAGRを記録すると予想される。

流通チャネルに基づき、経皮薬物送達システム市場は病院薬局、小売薬局、オンライン薬局、その他に区分される。病院薬局セグメントが2022年の市場で最大のシェアを占めている。しかし、小売薬局セグメントは2022-2030年の間に市場で最も高いCAGRを記録すると予想されている。

経皮薬物送達システム市場：地域別概要

2022年の経皮吸収型薬物送達システムの世界市場で最大のシェアを占めたのは北米であった。同地域では、米国が経皮薬物送達システム市場で最大のシェアを占めており、2022〜2030年のCAGRが最も高くなると予測されている。米国心臓協会（AHA）によると、心血管疾患（CVD）は依然として米国における死亡原因の第1位である。CDCによると、2021年には、CVDは〜695,000人の死亡を占め、米国での死亡の〜5人に1人を占めている。心血管疾患、糖尿病、慢性疼痛状態、およびその他の慢性疾患の有病率の上昇は、効果的で便利な治療オプションに対する需要を促進している。医療用パッチは、非侵襲的で患者に優しいアプローチを提供し、薬物を投与してこれらの慢性疾患に関連する症状を管理する。ウェアラブル・センサやフレキシブル・エレクトロニクスなど、TDDSの継続的な進歩が経皮薬物送達システム市場の成長に寄与している。これらの進歩により、より正確な投与、患者モニタリングの強化、患者のコンプライアンス向上が可能になる。Biomaterials Research社が2021年に発行した「Recent advances in transdermal drug delivery systems（経皮薬物送達システムにおける最近の進歩）」と題する報告書によると、マイクロニードルはTDDSモダリティの中でも大きな注目を集めており、マイクロニードルの利点を組み合わせることで、より高い治療効率と効果を得るために、既存の単純な塗布タイプやパッチタイプのニードルの限界を克服している。このようなTDDSの進歩は、心血管・中枢神経系疾患、糖尿病、神経筋疾患、感染症・局所感染症などの蔓延を抑制する原動力となり得る。

個々の患者に合わせて治療を行う個別化医薬品のトレンドの高まりが、制御された標的薬物送達を提供する医療用パッチの開発を後押ししている。このカスタマイズによって、患者の転帰が改善され、治療効果が向上する。例えば、2020年、Reddy's Laboratories社は、NitroDur（ニトログリセリン）経皮注入システムの正規ジェネリック・バージョンを米国市場で発売した。在宅医療や患者の遠隔モニタリングが重視されるようになる中、医療用パッチは従来の医療環境以外でも薬剤の投与やバイタルサインのモニタリングができる便利なソリューションを提供している。米国の経皮薬物送達システム市場は、慢性疾患の有病率の増加、技術進歩の高まり、個別化医薬品への注目の高まりといった要因の影響を受けている。

経皮ドラッグデリバリーシステム市場に関するレポート作成時に参照した主な一次および二次情報源には、世界銀行データ、国民保健サービス（NHS）、FDA（食品医薬品局）、EMA（欧州医薬品庁）、WHO（世界保健機関）などがある。

ページTOPに戻る


目次

TABLE OF CONTENTS

1. Introduction
1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
2.2 Transdermal Drug Delivery System Market, by Geography (US$ Million)
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Transdermal Drug Delivery System Market Landscape
4.1 Overview
4.2 Global PEST Analysis
5. Transdermal Drug Delivery System Market - Key Industry Dynamics
5.1 Market Drivers
5.1.1 Increasing Prevalence of Chronic Diseases
5.1.2 Growing Demand for Noninvasive Drug Delivery Devices
5.1.3 High Demand for Self-Administration of Drugs
5.2 Market Restraints
5.2.1 Adverse Effects and Recall of Transdermal Drug Delivery Systems
5.3 Market Opportunities
5.3.1 Advancements in Smart Patches and 3D-Printed Patches
5.4 Future Trends
5.4.1 Strategic Initiatives by Manufacturers
5.5 Impact Analysis
6. Transdermal Drug Delivery System Market - Global Market Analysis
6.1 Transdermal Drug Delivery System Market Revenue (US$ Mn), 2022 – 2030
7. Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 – by Product
7.1 Overview
7.2 Transdermal Drug Delivery System Market Revenue Share, by Product 2022 & 2030 (%)
7.3 Transdermal Patches
7.3.1 Overview
7.3.2 Transdermal Patches: Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
7.3.2.1 Drug-in-Adhesive Patches
7.3.2.1.1 Overview
7.3.2.1.2 Drug-in-Adhesive Patches: Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
7.3.2.2 Matrix Patches
7.3.2.2.1 Overview
7.3.2.2.2 Matrix Patches: Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
7.3.2.3 Reservoir Membrane Patches
7.3.2.3.1 Overview
7.3.2.3.2 Reservoir Membrane Patches: Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
7.3.2.4 Vapor Patches
7.3.2.4.1 Overview
7.3.2.4.2 Vapor Patches: Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
7.4 Transdermal Gels
7.4.1 Overview
7.4.2 Transdermal Gels: Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
7.5 Transdermal Sprays
7.5.1 Overview
7.5.2 Transdermal Sprays: Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
7.6 Others
7.6.1 Overview
7.6.2 Others: Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
8. Global Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 – by Application
8.1 Overview
8.2 Transdermal Drug Delivery System Market Revenue Share, by Application 2022 & 2030 (%)
8.3 Cardiovascular Diseases
8.3.1 Overview
8.3.2 Cardiovascular Diseases: Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
8.4 Central Nervous System Disorders
8.4.1 Overview
8.4.2 Central Nervous System Disorders: Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
8.5 Pain Management
8.5.1 Overview
8.5.2 Pain Management: Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
8.5.2.1 Opioid
8.5.2.1.1 Overview
8.5.2.1.2 Opioid: Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
8.5.2.2 Non-Opioid
8.5.2.2.1 Overview
8.5.2.2.2 Non-Opioid: Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
8.6 Hormonal Applications
8.6.1 Overview
8.6.2 Hormonal Applications: Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
8.6.2.1 Transdermal Estrogen & Progesterone Therapy
8.6.2.1.1 Overview
8.6.2.1.2 Transdermal Estrogen & Progesterone Therapy: Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
8.6.2.2 Testosterone Replacement
8.6.2.2.1 Overview
8.6.2.2.2 Testosterone Replacement: Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
8.7 Other Application
8.7.1 Overview
8.7.2 Other Application: Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
9. Global Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 – by Distribution Channel
9.1 Overview
9.2 Transdermal Drug Delivery System Market Revenue Share, by Distribution Channel 2022 & 2030 (%)
9.3 Hospital Pharmacies
9.3.1 Overview
9.3.2 Hospital Pharmacies: Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
9.4 Retail Pharmacies
9.4.1 Overview
9.4.2 Retail Pharmacies: Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
9.5 Online Pharmacies
9.5.1 Overview
9.5.2 Online Pharmacies: Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
9.6 Others
9.6.1 Overview
9.6.2 Others: Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
10. Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 – Geographic Analysis
10.1 North America: Transdermal Drug Delivery System Market
10.1.1 Overview
10.1.2 North America: Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
10.1.3 North America: Transdermal Drug Delivery System Market, by Product, 2020–2030 (US$ Million)
10.1.3.1 North America: Transdermal Drug Delivery System Market, For Transdermal Patches by Product, 2020–2030 (US$ Million)
10.1.4 North America: Transdermal Drug Delivery System Market, by Application, 2020–2030 (US$ Million)
10.1.4.1 North America: Transdermal Drug Delivery System Market, For Pain Management by Application, 2020–2030 (US$ Million)
10.1.4.2 North America: Transdermal Drug Delivery System Market, For Hormonal Applications by Application, 2020–2030 (US$ Million)
10.1.5 North America: Transdermal Drug Delivery System Market, by Distribution Channel, 2020–2030 (US$ Million)
10.1.5.1 US: Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
10.1.5.1.1 Overview
10.1.5.1.2 US: Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
10.1.5.1.3 US: Transdermal Drug Delivery System Market, by Product, 2020–2030 (US$ Million)
10.1.5.1.3.1 US: Transdermal Drug Delivery System Market, For Transdermal Patches by Product, 2020–2030 (US$ Million)
10.1.5.1.4 US: Transdermal Drug Delivery System Market, by Application, 2020–2030 (US$ Million)
10.1.5.1.4.1 US: Transdermal Drug Delivery System Market, For Pain Management by Application, 2020–2030 (US$ Million)
10.1.5.1.4.2 US: Transdermal Drug Delivery System Market, For Hormonal Applications by Application, 2020–2030 (US$ Million)
10.1.5.1.5 US: Transdermal Drug Delivery System Market, by Distribution Channel, 2020–2030 (US$ Million)
10.1.5.2 Canada: Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
10.1.5.2.1 Overview
10.1.5.2.2 Canada: Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
10.1.5.2.3 Canada: Transdermal Drug Delivery System Market, by Product, 2020–2030 (US$ Million)
10.1.5.2.3.1 Canada: Transdermal Drug Delivery System Market, For Transdermal Patches by Product, 2020–2030 (US$ Million)
10.1.5.2.4 Canada: Transdermal Drug Delivery System Market, by Application, 2020–2030 (US$ Million)
10.1.5.2.4.1 Canada: Transdermal Drug Delivery System Market, For Pain Management by Application, 2020–2030 (US$ Million)
10.1.5.2.4.2 Canada: Transdermal Drug Delivery System Market, For Hormonal Applications by Application, 2020–2030 (US$ Million)
10.1.5.2.5 Canada: Transdermal Drug Delivery System Market, by Distribution Channel, 2020–2030 (US$ Million)
10.1.5.3 Mexico: Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
10.1.5.3.1 Overview
10.1.5.3.2 Mexico: Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
10.1.5.3.3 Mexico: Transdermal Drug Delivery System Market, by Product, 2020–2030 (US$ Million)
10.1.5.3.3.1 Mexico: Transdermal Drug Delivery System Market, For Transdermal Patches by Product, 2020–2030 (US$ Million)
10.1.5.3.4 Mexico: Transdermal Drug Delivery System Market, by Application, 2020–2030 (US$ Million)
10.1.5.3.4.1 Mexico: Transdermal Drug Delivery System Market, For Pain Management by Application, 2020–2030 (US$ Million)
10.1.5.3.4.2 Mexico: Transdermal Drug Delivery System Market, For Hormonal Applications by Application, 2020–2030 (US$ Million)
10.1.5.3.5 Mexico: Transdermal Drug Delivery System Market, by Distribution Channel, 2020–2030 (US$ Million)
10.2 Europe: Transdermal Drug Delivery System Market
10.2.1 Overview
10.2.2 Europe: Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
10.2.3 Europe: Transdermal Drug Delivery System Market, by Product, 2020–2030 (US$ Million)
10.2.3.1 Europe: Transdermal Drug Delivery System Market, For Transdermal Patches by Product, 2020–2030 (US$ Million)
10.2.4 Europe: Transdermal Drug Delivery System Market, by Application, 2020–2030 (US$ Million)
10.2.4.1 Europe: Transdermal Drug Delivery System Market, For Pain Management by Application, 2020–2030 (US$ Million)
10.2.4.2 Europe: Transdermal Drug Delivery System Market, For Hormonal Applications by Application, 2020–2030 (US$ Million)
10.2.5 Europe: Transdermal Drug Delivery System Market, by Distribution Channel, 2020–2030 (US$ Million)
10.2.6 Europe: Transdermal Drug Delivery System Market, by Country, 2022 & 2030 (%)
10.2.6.1 Germany: Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
10.2.6.1.1 Overview
10.2.6.1.2 Germany: Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
10.2.6.1.3 Germany: Transdermal Drug Delivery System Market, by Product, 2020–2030 (US$ Million)
10.2.6.1.3.1 Germany: Transdermal Drug Delivery System Market, For Transdermal Patches by Product, 2020–2030 (US$ Million)
10.2.6.1.4 Germany: Transdermal Drug Delivery System Market, by Application, 2020–2030 (US$ Million)
10.2.6.1.4.1 Germany: Transdermal Drug Delivery System Market, For Pain Management by Application, 2020–2030 (US$ Million)
10.2.6.1.4.2 Germany: Transdermal Drug Delivery System Market, For Hormonal Applications by Application, 2020–2030 (US$ Million)
10.2.6.1.5 Germany: Transdermal Drug Delivery System Market, by Distribution Channel, 2020–2030 (US$ Million)
10.2.6.2 France: Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
10.2.6.2.1 Overview
10.2.6.2.2 France: Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
10.2.6.2.3 France: Transdermal Drug Delivery System Market, by Product, 2020–2030 (US$ Million)
10.2.6.2.3.1 France: Transdermal Drug Delivery System Market, For Transdermal Patches by Product, 2020–2030 (US$ Million)
10.2.6.2.4 France: Transdermal Drug Delivery System Market, by Application, 2020–2030 (US$ Million)
10.2.6.2.4.1 France: Transdermal Drug Delivery System Market, For Pain Management by Application, 2020–2030 (US$ Million)
10.2.6.2.4.2 France: Transdermal Drug Delivery System Market, For Hormonal Applications by Application, 2020–2030 (US$ Million)
10.2.6.2.5 France: Transdermal Drug Delivery System Market, by Distribution Channel, 2020–2030 (US$ Million)
10.2.6.3 UK: Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
10.2.6.3.1 Overview
10.2.6.3.2 UK: Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
10.2.6.3.3 UK: Transdermal Drug Delivery System Market, by Product, 2020–2030 (US$ Million)
10.2.6.3.3.1 UK: Transdermal Drug Delivery System Market, For Transdermal Patches by Product, 2020–2030 (US$ Million)
10.2.6.3.4 UK: Transdermal Drug Delivery System Market, by Application, 2020–2030 (US$ Million)
10.2.6.3.4.1 UK: Transdermal Drug Delivery System Market, For Pain Management by Application, 2020–2030 (US$ Million)
10.2.6.3.4.2 UK: Transdermal Drug Delivery System Market, For Hormonal Applications by Application, 2020–2030 (US$ Million)
10.2.6.3.5 UK: Transdermal Drug Delivery System Market, by Distribution Channel, 2020–2030 (US$ Million)
10.2.6.4 Italy: Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
10.2.6.4.1 Overview
10.2.6.4.2 Italy: Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
10.2.6.4.3 Italy: Transdermal Drug Delivery System Market, by Product, 2020–2030 (US$ Million)
10.2.6.4.3.1 Italy: Transdermal Drug Delivery System Market, For Transdermal Patches by Product, 2020–2030 (US$ Million)
10.2.6.4.4 Italy: Transdermal Drug Delivery System Market, by Application, 2020–2030 (US$ Million)
10.2.6.4.4.1 Italy: Transdermal Drug Delivery System Market, For Pain Management by Application, 2020–2030 (US$ Million)
10.2.6.4.4.2 Italy: Transdermal Drug Delivery System Market, For Hormonal Applications by Application, 2020–2030 (US$ Million)
10.2.6.4.5 Italy: Transdermal Drug Delivery System Market, by Distribution Channel, 2020–2030 (US$ Million)
10.2.6.5 Spain: Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
10.2.6.5.1 Overview
10.2.6.5.2 Spain: Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
10.2.6.5.3 Spain: Transdermal Drug Delivery System Market, by Product, 2020–2030 (US$ Million)
10.2.6.5.3.1 Spain: Transdermal Drug Delivery System Market, For Transdermal Patches by Product, 2020–2030 (US$ Million)
10.2.6.5.4 Spain: Transdermal Drug Delivery System Market, by Application, 2020–2030 (US$ Million)
10.2.6.5.4.1 Spain: Transdermal Drug Delivery System Market, For Pain Management by Application, 2020–2030 (US$ Million)
10.2.6.5.4.2 Spain: Transdermal Drug Delivery System Market, For Hormonal Applications by Application, 2020–2030 (US$ Million)
10.2.6.5.5 Spain: Transdermal Drug Delivery System Market, by Distribution Channel, 2020–2030 (US$ Million)
10.2.6.6 Rest of Europe: Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
10.2.6.6.1 Overview
10.2.6.6.2 Rest of Europe: Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
10.2.6.6.3 Rest of Europe: Transdermal Drug Delivery System Market, by Product, 2020–2030 (US$ Million)
10.2.6.6.3.1 Rest of Europe: Transdermal Drug Delivery System Market, For Transdermal Patches by Product, 2020–2030 (US$ Million)
10.2.6.6.4 Rest of Europe: Transdermal Drug Delivery System Market, by Application, 2020–2030 (US$ Million)
10.2.6.6.4.1 Rest of Europe: Transdermal Drug Delivery System Market, For Pain Management by Application, 2020–2030 (US$ Million)
10.2.6.6.4.2 Rest of Europe: Transdermal Drug Delivery System Market, For Hormonal Applications by Application, 2020–2030 (US$ Million)
10.2.6.6.5 Rest of Europe: Transdermal Drug Delivery System Market, by Distribution Channel, 2020–2030 (US$ Million)
10.3 Asia Pacific: Transdermal Drug Delivery System Market
10.3.1 Overview
10.3.2 Asia Pacific: Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
10.3.3 Asia Pacific: Transdermal Drug Delivery System Market, by Product, 2020–2030 (US$ Million)
10.3.3.1 Asia Pacific: Transdermal Drug Delivery System Market, For Transdermal Patches by Product, 2020–2030 (US$ Million)
10.3.4 Asia Pacific: Transdermal Drug Delivery System Market, by Application, 2020–2030 (US$ Million)
10.3.4.1 Asia Pacific: Transdermal Drug Delivery System Market, For Pain Management by Application, 2020–2030 (US$ Million)
10.3.4.2 Asia Pacific: Transdermal Drug Delivery System Market, For Hormonal Applications by Application, 2020–2030 (US$ Million)
10.3.5 Asia Pacific: Transdermal Drug Delivery System Market, by Distribution Channel, 2020–2030 (US$ Million)
10.3.6 Asia Pacific: Transdermal Drug Delivery System Market, by Country, 2022 & 2030 (%)
10.3.6.1 China: Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
10.3.6.1.1 Overview
10.3.6.1.2 China: Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
10.3.6.1.3 China: Transdermal Drug Delivery System Market, by Product, 2020–2030 (US$ Million)
10.3.6.1.3.1 China: Transdermal Drug Delivery System Market, For Transdermal Patches by Product, 2020–2030 (US$ Million)
10.3.6.1.4 China: Transdermal Drug Delivery System Market, by Application, 2020–2030 (US$ Million)
10.3.6.1.4.1 China: Transdermal Drug Delivery System Market, For Pain Management by Application, 2020–2030 (US$ Million)
10.3.6.1.4.2 China: Transdermal Drug Delivery System Market, For Hormonal Applications by Application, 2020–2030 (US$ Million)
10.3.6.1.5 China: Transdermal Drug Delivery System Market, by Distribution Channel, 2020–2030 (US$ Million)
10.3.6.2 Japan: Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
10.3.6.2.1 Overview
10.3.6.2.2 Japan: Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
10.3.6.2.3 Japan: Transdermal Drug Delivery System Market, by Product, 2020–2030 (US$ Million)
10.3.6.2.3.1 Japan: Transdermal Drug Delivery System Market, For Transdermal Patches by Product, 2020–2030 (US$ Million)
10.3.6.2.4 Japan: Transdermal Drug Delivery System Market, by Application, 2020–2030 (US$ Million)
10.3.6.2.4.1 Japan: Transdermal Drug Delivery System Market, For Pain Management by Application, 2020–2030 (US$ Million)
10.3.6.2.4.2 Japan: Transdermal Drug Delivery System Market, For Hormonal Applications by Application, 2020–2030 (US$ Million)
10.3.6.2.5 Japan: Transdermal Drug Delivery System Market, by Distribution Channel, 2020–2030 (US$ Million)
10.3.6.3 India: Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
10.3.6.3.1 Overview
10.3.6.3.2 India: Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
10.3.6.3.3 India: Transdermal Drug Delivery System Market, by Product, 2020–2030 (US$ Million)
10.3.6.3.3.1 India: Transdermal Drug Delivery System Market, For Transdermal Patches by Product, 2020–2030 (US$ Million)
10.3.6.3.4 India: Transdermal Drug Delivery System Market, by Application, 2020–2030 (US$ Million)
10.3.6.3.4.1 India: Transdermal Drug Delivery System Market, For Pain Management by Application, 2020–2030 (US$ Million)
10.3.6.3.4.2 India: Transdermal Drug Delivery System Market, For Hormonal Applications by Application, 2020–2030 (US$ Million)
10.3.6.3.5 India: Transdermal Drug Delivery System Market, by Distribution Channel, 2020–2030 (US$ Million)
10.3.6.4 Australia: Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
10.3.6.4.1 Overview
10.3.6.4.2 Australia: Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
10.3.6.4.3 Australia: Transdermal Drug Delivery System Market, by Product, 2020–2030 (US$ Million)
10.3.6.4.3.1 Australia: Transdermal Drug Delivery System Market, For Transdermal Patches by Product, 2020–2030 (US$ Million)
10.3.6.4.4 Australia: Transdermal Drug Delivery System Market, by Application, 2020–2030 (US$ Million)
10.3.6.4.4.1 Australia: Transdermal Drug Delivery System Market, For Pain Management by Application, 2020–2030 (US$ Million)
10.3.6.4.4.2 Australia: Transdermal Drug Delivery System Market, For Hormonal Applications by Application, 2020–2030 (US$ Million)
10.3.6.4.5 Australia: Transdermal Drug Delivery System Market, by Distribution Channel, 2020–2030 (US$ Million)
10.3.6.5 South Korea: Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
10.3.6.5.1 Overview
10.3.6.5.2 South Korea: Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
10.3.6.5.3 South Korea: Transdermal Drug Delivery System Market, by Product, 2020–2030 (US$ Million)
10.3.6.5.3.1 South Korea: Transdermal Drug Delivery System Market, For Transdermal Patches by Product, 2020–2030 (US$ Million)
10.3.6.5.4 South Korea: Transdermal Drug Delivery System Market, by Application, 2020–2030 (US$ Million)
10.3.6.5.4.1 South Korea: Transdermal Drug Delivery System Market, For Pain Management by Application, 2020–2030 (US$ Million)
10.3.6.5.4.2 South Korea: Transdermal Drug Delivery System Market, For Hormonal Applications by Application, 2020–2030 (US$ Million)
10.3.6.5.5 South Korea: Transdermal Drug Delivery System Market, by Distribution Channel, 2020–2030 (US$ Million)
10.3.6.6 Rest of Asia Pacific: Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
10.3.6.6.1 Overview
10.3.6.6.2 Rest of Asia Pacific: Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
10.3.6.6.3 Rest of Asia Pacific: Transdermal Drug Delivery System Market, by Product, 2020–2030 (US$ Million)
10.3.6.6.3.1 Rest of Asia Pacific: Transdermal Drug Delivery System Market, For Transdermal Patches by Product, 2020–2030 (US$ Million)
10.3.6.6.4 Rest of Asia Pacific: Transdermal Drug Delivery System Market, by Application, 2020–2030 (US$ Million)
10.3.6.6.4.1 Rest of Asia Pacific: Transdermal Drug Delivery System Market, For Pain Management by Application, 2020–2030 (US$ Million)
10.3.6.6.4.2 Rest of Asia Pacific: Transdermal Drug Delivery System Market, For Hormonal Applications by Application, 2020–2030 (US$ Million)
10.3.6.6.5 Rest of Asia Pacific: Transdermal Drug Delivery System Market, by Distribution Channel, 2020–2030 (US$ Million)
10.4 Middle East & Africa Transdermal Drug Delivery System Market
10.4.1 Overview
10.4.2 Middle East & Africa: Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
10.4.3 Middle East & Africa: Transdermal Drug Delivery System Market, by Product, 2020–2030 (US$ Million)
10.4.3.1 Middle East & Africa: Transdermal Drug Delivery System Market, For Transdermal Patches by Product, 2020–2030 (US$ Million)
10.4.4 Middle East & Africa: Transdermal Drug Delivery System Market, by Application, 2020–2030 (US$ Million)
10.4.4.1 Middle East & Africa: Transdermal Drug Delivery System Market, For Pain Management by Application, 2020–2030 (US$ Million)
10.4.4.2 Middle East & Africa: Transdermal Drug Delivery System Market, For Hormonal Applications by Application, 2020–2030 (US$ Million)
10.4.5 Middle East & Africa: Transdermal Drug Delivery System Market, by Distribution Channel, 2020–2030 (US$ Million)
10.4.5.1 South Africa: Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
10.4.5.1.1 Overview
10.4.5.1.2 South Africa: Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
10.4.5.1.3 South Africa: Transdermal Drug Delivery System Market, by Product, 2020–2030 (US$ Million)
10.4.5.1.3.1 South Africa: Transdermal Drug Delivery System Market, For Transdermal Patches by Product, 2020–2030 (US$ Million)
10.4.5.1.4 South Africa: Transdermal Drug Delivery System Market, by Application, 2020–2030 (US$ Million)
10.4.5.1.4.1 South Africa: Transdermal Drug Delivery System Market, For Pain Management by Application, 2020–2030 (US$ Million)
10.4.5.1.4.2 South Africa: Transdermal Drug Delivery System Market, For Hormonal Applications by Application, 2020–2030 (US$ Million)
10.4.5.1.5 South Africa: Transdermal Drug Delivery System Market, by Distribution Channel, 2020–2030 (US$ Million)
10.4.5.2 Saudi Arabia: Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
10.4.5.2.1 Overview
10.4.5.2.2 Saudi Arabia: Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
10.4.5.2.3 Saudi Arabia: Transdermal Drug Delivery System Market, by Product, 2020–2030 (US$ Million)
10.4.5.2.3.1 Saudi Arabia: Transdermal Drug Delivery System Market, For Transdermal Patches by Product, 2020–2030 (US$ Million)
10.4.5.2.4 Saudi Arabia: Transdermal Drug Delivery System Market, by Application, 2020–2030 (US$ Million)
10.4.5.2.4.1 Saudi Arabia: Transdermal Drug Delivery System Market, For Pain Management by Application, 2020–2030 (US$ Million)
10.4.5.2.4.2 Saudi Arabia: Transdermal Drug Delivery System Market, For Hormonal Applications by Application, 2020–2030 (US$ Million)
10.4.5.2.5 Saudi Arabia: Transdermal Drug Delivery System Market, by Distribution Channel, 2020–2030 (US$ Million)
10.4.5.3 UAE: Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
10.4.5.3.1 Overview
10.4.5.3.2 UAE: Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
10.4.5.3.3 UAE: Transdermal Drug Delivery System Market, by Product, 2020–2030 (US$ Million)
10.4.5.3.3.1 UAE: Transdermal Drug Delivery System Market, For Transdermal Patches by Product, 2020–2030 (US$ Million)
10.4.5.3.4 UAE: Transdermal Drug Delivery System Market, by Application, 2020–2030 (US$ Million)
10.4.5.3.4.1 UAE: Transdermal Drug Delivery System Market, For Pain Management by Application, 2020–2030 (US$ Million)
10.4.5.3.4.2 UAE: Transdermal Drug Delivery System Market, For Hormonal Applications by Application, 2020–2030 (US$ Million)
10.4.5.3.5 UAE: Transdermal Drug Delivery System Market, by Distribution Channel, 2020–2030 (US$ Million)
10.4.5.4 Rest of Middle East & Africa: Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
10.4.5.4.1 Overview
10.4.5.4.2 Rest of Middle East & Africa: Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
10.4.5.4.3 Rest of Middle East & Africa: Transdermal Drug Delivery System Market, by Product, 2020–2030 (US$ Million)
10.4.5.4.3.1 Rest of Middle East & Africa: Transdermal Drug Delivery System Market, For Transdermal Patches by Product, 2020–2030 (US$ Million)
10.4.5.4.4 Rest of Middle East & Africa: Transdermal Drug Delivery System Market, by Application, 2020–2030 (US$ Million)
10.4.5.4.4.1 Rest of Middle East & Africa: Transdermal Drug Delivery System Market, For Pain Management by Application, 2020–2030 (US$ Million)
10.4.5.4.4.2 Rest of Middle East & Africa: Transdermal Drug Delivery System Market, For Hormonal Applications by Application, 2020–2030 (US$ Million)
10.4.5.4.5 Rest of Middle East & Africa: Transdermal Drug Delivery System Market, by Distribution Channel, 2020–2030 (US$ Million)
10.5 South & Central America: Transdermal Drug Delivery System Market
10.5.1 Overview
10.5.2 South & Central America: Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
10.5.3 South & Central America: Transdermal Drug Delivery System Market, by Product, 2020–2030 (US$ Million)
10.5.3.1 South & Central America: Transdermal Drug Delivery System Market, For Transdermal Patches by Product, 2020–2030 (US$ Million)
10.5.4 South & Central America: Transdermal Drug Delivery System Market, By Application, 2020–2030 (US$ Million)
10.5.4.1 South & Central America: Transdermal Drug Delivery System Market, For Pain Management by Application, 2020–2030 (US$ Million)
10.5.4.2 South & Central America: Transdermal Drug Delivery System Market, For Hormonal Applications by Application, 2020–2030 (US$ Million)
10.5.5 South & Central America: Transdermal Drug Delivery System Market, By Distribution Channel, 2020–2030 (US$ Million)
10.5.6 South & Central America: Transdermal Drug Delivery System Market Share by Country – 2022 & 2030, (%)
10.5.6.1 Brazil: Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
10.5.6.1.1 Overview
10.5.6.2 Brazil: Transdermal Drug Delivery System Market- Revenue and Forecasts to 2030 (US$ Million)
10.5.6.2.1 Brazil: Transdermal Drug Delivery System Market, by Product, 2020–2030 (US$ Million)
10.5.6.2.1.1 Brazil: Transdermal Drug Delivery System Market, For Transdermal Patches by Product, 2020–2030 (US$ Million)
10.5.6.2.2 Brazil: Transdermal Drug Delivery System Market, by Application, 2020–2030 (US$ Million)
10.5.6.2.2.1 Brazil: Transdermal Drug Delivery System Market, For Pain Management by Application, 2020–2030 (US$ Million)
10.5.6.2.2.2 Brazil: Transdermal Drug Delivery System Market, For Hormonal Applications by Application, 2020–2030 (US$ Million)
10.5.6.2.3 Brazil: Transdermal Drug Delivery System Market, by Distribution Channel, 2020–2030 (US$ Million)
10.5.6.3 Argentina: Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
10.5.6.3.1 Overview
10.5.6.4 Argentina: Transdermal Drug Delivery System Market- Revenue and Forecasts to 2030 (US$ Million)
10.5.6.4.1 Argentina: Transdermal Drug Delivery System Market, by Product, 2020–2030 (US$ Million)
10.5.6.4.1.1 Argentina: Transdermal Drug Delivery System Market, For Transdermal Patches by Product, 2020–2030 (US$ Million)
10.5.6.4.2 Argentina: Transdermal Drug Delivery System Market, by Application, 2020–2030 (US$ Million)
10.5.6.4.2.1 Argentina: Transdermal Drug Delivery System Market, For Pain Management by Application, 2020–2030 (US$ Million)
10.5.6.4.2.2 Argentina: Transdermal Drug Delivery System Market, For Hormonal Applications by Application, 2020–2030 (US$ Million)
10.5.6.4.3 Argentina: Transdermal Drug Delivery System Market, by Distribution Channel, 2020–2030 (US$ Million)
10.5.6.5 Rest of South & Central America: Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
10.5.6.5.1 Overview
10.5.6.6 Rest of South & Central America: Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
10.5.6.6.1 Rest of South & Central America: Transdermal Drug Delivery System Market, by Product, 2020–2030 (US$ Million)
10.5.6.6.1.1 Rest of South & Central America: Transdermal Drug Delivery System Market, For Transdermal Patches by Product, 2020–2030 (US$ Million)
10.5.6.6.2 Rest of South & Central America: Transdermal Drug Delivery System Market, by Application, 2020–2030 (US$ Million)
10.5.6.6.2.1 Rest of South & Central America: Transdermal Drug Delivery System Market, For Pain Management by Application, 2020–2030 (US$ Million)
10.5.6.6.2.2 Rest of South & Central America: Transdermal Drug Delivery System Market, For Hormonal Applications by Application, 2020–2030 (US$ Million)
10.5.6.6.3 Rest of South & Central America: Transdermal Drug Delivery System Market, by Distribution Channel, 2020–2030 (US$ Million)
11. Transdermal Drug Delivery System Market Industry Landscape
11.1 Overview
11.2 Growth Strategies in the Transdermal Drug Delivery System Market
11.3 Inorganic Growth Strategies
11.3.1 Overview
11.4 Organic Growth Strategies
11.4.1 Overview
12. Company Profiles
12.1 Novartis AG
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Johnson & Johnson
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 GSK Plc
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Viatris Inc
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Boehringer Ingelheim International GmbH
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Hisamitsu Pharmaceutical Co Inc
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 Luye Pharma Group Ltd
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 Lavipharm SA
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
12.9 Purdue Pharma LP
12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Products and Services
12.9.4 Financial Overview
12.9.5 SWOT Analysis
12.9.6 Key Developments
12.10 UCB SA
12.10.1 Key Facts
12.10.2 Business Description
12.10.3 Products and Services
12.10.4 Financial Overview
12.10.5 SWOT Analysis
12.10.6 Key Developments
13. Appendix
13.1 About Us
13.2 Glossary of Terms

　

ページTOPに戻る


　

Summary

The global transdermal drug delivery systems market is expected to reach US$ 51.949 billion in 2030 from US$ 37.230 billion in 2022. The market is estimated to grow with a CAGR of 4.3% from 2022 to 2030.

The key factors driving the market's growth include growing areas of application of transdermal drug delivery systems and rising cases of spinal cord injury. However, the post-surgical complications hinder the market growth.

Market Opportunities of Transdermal Drug Delivery Systems Market

A transdermal drug administration route is novel and one of the reliable means of sustained drug delivery. With significant research being conducted in this field and the increasing interest of researchers in this form of drug delivery, a large number of transdermal patches are likely to reach the marketplace in the future. Transdermal patches are used to deliver drugs such as nicotine, fentanyl, nitroglycerin, and clonidine to treat various medical conditions. Recently, these patches have been explored to deliver biologics in various applications. Smart patches are equipped with sensors and other technologies to monitor patient conditions and adjust drug delivery accordingly. In January 2023, a lead scientist at Swansea University developed a new smart patch to detect proinflammatory biomarkers of neurodegenerative diseases such as Parkinson's and Alzheimer's using the microneedle technology. These smart patches comprise numerous microneedles designed to penetrate the skin barrier in a minimally invasive manner, followed by monitoring the biomarkers of clinical significance. They can be self-administered for point-of-care diagnosis at general practices or at home. This innovative research can potentially change the landscape of early neurodegenerative disease detection.

According to an article titled "3D-Printed Products for Topical Skin Applications: From Personalized Dressings to Drug Delivery," published in the National Library of Medicine in November 2021, personalized 3D-printed patches that conform to the skin surface can be used for acetyl-hexapeptide 3 (AHP-3) delivery. In this study, two liquid monomers—polyethylene glycol diacrylate (PEGDA) and vinylpyrrolidone (VP)—were used in different proportions to improve the mechanical strength, polymerization rate, and swelling rate of the final polymer. Optimal drug loading on the resin indicated that AHP-3 remained stable throughout the manufacturing process and had no effect on the physical properties of the final polymer. Using a 3D scanned facial model, a personalized patch was designed in computer-aided design software, and it was fabricated in optimized resin using a digital light processing 3D printer. The in-vitro characterization of prepared transdermal patches has shown their ability to penetrate human cadaver skin, further remaining intact upon compression. "3D-Printed Products for Topical Skin Applications: From Personalized Dressings to Drug Delivery" is the first study demonstrating personalized patches made using photopolymers, and it has introduced a novel approach to improve the transdermal delivery of drugs for effective wrinkle management.

Thus, the adoption of 3D printing technology and smart patches is likely to offer opportunities to the transdermal drug delivery systems market in the coming years.

Factors Hampering Transdermal Drug Delivery Systems Market

Currently marketed transdermal drug delivery systems (TDDS), transmucosal drug delivery systems (TMDS), and topical patches may retain 10–95% of the initial total quantity of the drug as a residual drug after the intended use period. This raises a potential safety issue for patients, and their family members and caregivers. For example, adverse events due to a patient’s failure to remove TDDS at the end of the intended use period generally result in an increased or prolonged pharmacological effect of the drug. Some children have also been reported to have died from accidental exposure to discarded TDDS. Below are some of the product recalls and withdrawals by the manufacturers.

In February 2023, Aveva Drug Delivery Systems Inc recalled two lots of buprenorphine transdermal systems for failing to meet impurity/degradation specifications. Aveva Drug Delivery Systems voluntarily initiated the recall on February 15, 2023, which was designated as a Class III recall by the FDA on March 14, 2023. Under this recall classification, the use of the product is not likely to cause any major harm. In September 2020, Teva Pharmaceuticals USA recalled two lots of buprenorphine patches. The recall affected 32,543 cartons of buprenorphine transdermal systems, 5 mcg/hour, four transdermal systems per carton (patch NDC 0093-3656-21, carton NDC 0093-3656-40), from lots 190017 and 190161. The product was manufactured by 3M Drug Delivery Systems for Teva Pharmaceuticals and distributed in the US and Puerto Rico. Followed by its voluntary recall by Teva Pharmaceuticals on September 4, 2020, the FDA designated the recall Class II on October 1, 2020. Continuing the use of Class II recall products may cause temporary or medically reversible adverse health consequences if used. While remote, a possibility of serious harm exists. Further, in April 2018, the FDA sent a Warning Letter to Phase 4 Pharmaceutical LLC. Instead of manufacturing transdermal drug types, the firm was functioning as a re-packager of over-the-counter (OTC) transdermal drug types, and the FDA found several violations of CGMP that affected the quality of its products. In April 2019, Alvogen, Inc. announced a voluntary, nationwide recall of two lots (or batches) of Fentanyl Transdermal System, 12 mcg/h transdermal patches, because of a label mix-up. Thus, adverse effects and recalls of transdermal drug delivery systems hinder the market growth.

Transdermal Drug Delivery Systems Market: Segmental Overview

Based on product, the transdermal drug delivery system market is segmented into transdermal patches, transdermal gels, transdermal sprays, and others. The transdermal patch segment is further segmented into drug-in-adhesive patches, reservoir membrane patches, matrix patches, and vapor patches. The transdermal patches segment held the largest share of the market in 2022, while transdermal gels is anticipated to register the highest CAGR during 2022–2030. A transdermal patch is a drug delivery system attached to a patient’s skin to deliver medication through the skin.

The transdermal drug delivery system market, by application, has been segmented into cardiovascular diseases, central nervous system disorders, hormonal applications, pain management, and other applications. The market for the pain management segment is sub-segmented into opioid application and non-opioid application. The market for hormonal application segment is further segmented into transdermal estrogen therapy and testosterone replacement therapy. The pain management segment held the largest share of the market in 2022. Central nervous system disorders segment is expected to register the highest CAGR in the market during 2022–2030.

Based on the distribution channel, the transdermal drug delivery system market is segmented into hospital pharmacies, retail pharmacies, online pharmacies, and others. The hospital pharmacies segment held the largest share of the market in 2022. However, the retail pharmacies segment is expected to register the highest CAGR in the market during 2022–2030.

Transdermal Drug Delivery Systems Market: Geographical Overview

North America accounted for the largest share of the global transdermal drug delivery systems market in 2022. In the region, the US held the largest transdermal drug delivery systems market share and is anticipated to register the highest CAGR during 2022-2030. According to the American Heart Association (AHA), cardiovascular disease (CVD) remains the leading cause of death in the US. According to the CDC, in 2021, CVD accounted for ~695,000 deaths and ~1 in 5 deaths in the US. The rising prevalence of cardiovascular disease, diabetes, chronic pain conditions, and other chronic diseases drives the demand for effective and convenient treatment options. Medical patches offer a noninvasive and patient-friendly approach to deliver medication and manage symptoms associated with these chronic conditions. Ongoing advancements in TDDS, such as wearable sensors and flexible electronics, contribute to the growth of the transdermal drug delivery system market. These advancements allow for more accurate dosing, enhanced patient monitoring, and improved patient compliance. According to a report titled "Recent advances in transdermal drug delivery systems," published by Biomaterials Research in 2021, microneedles attract significant attention among TDDS modalities, which overcome the limitations of the existing simple application type and patch-type needles by combining the advantages of microneedles to obtain higher treatment efficiency and effects. Advances in these TDDS can provide the driving force for controlling the prevalence of cardiovascular and central nervous system diseases, diabetes, neuromuscular diseases, and infectious and localized infectious diseases.

The growing trend of personalized medicines, where treatments are tailored to individual patients, has boosted the development of medical patches that offer controlled and targeted drug delivery. This customization allows for better patient outcomes and improved therapeutic efficacy. For instance, in 2020, Reddy's Laboratories launched an authorized generic version of NitroDur (nitroglycerin) transdermal infusion system in the US market. With the growing emphasis on home healthcare and remote patient monitoring, medical patches offer a convenient solution for delivering medications and monitoring vital signs outside traditional healthcare settings. The US transdermal drug delivery system market is influenced by factors such as the increasing prevalence of chronic diseases, rising technological advancements, and growing focus on personalized medicines.

A few of the major primary and secondary sources referred to while preparing the report on the transdermal drug delivery systems market are the World Bank Data, National Health Service (NHS), FDA (Food and Drug Administration), EMA (European Medicines Agency), and WHO (World Health Organization).



ページTOPに戻る


Table of Contents

TABLE OF CONTENTS

1. Introduction
1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
2.2 Transdermal Drug Delivery System Market, by Geography (US$ Million)
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Transdermal Drug Delivery System Market Landscape
4.1 Overview
4.2 Global PEST Analysis
5. Transdermal Drug Delivery System Market - Key Industry Dynamics
5.1 Market Drivers
5.1.1 Increasing Prevalence of Chronic Diseases
5.1.2 Growing Demand for Noninvasive Drug Delivery Devices
5.1.3 High Demand for Self-Administration of Drugs
5.2 Market Restraints
5.2.1 Adverse Effects and Recall of Transdermal Drug Delivery Systems
5.3 Market Opportunities
5.3.1 Advancements in Smart Patches and 3D-Printed Patches
5.4 Future Trends
5.4.1 Strategic Initiatives by Manufacturers
5.5 Impact Analysis
6. Transdermal Drug Delivery System Market - Global Market Analysis
6.1 Transdermal Drug Delivery System Market Revenue (US$ Mn), 2022 – 2030
7. Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 – by Product
7.1 Overview
7.2 Transdermal Drug Delivery System Market Revenue Share, by Product 2022 & 2030 (%)
7.3 Transdermal Patches
7.3.1 Overview
7.3.2 Transdermal Patches: Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
7.3.2.1 Drug-in-Adhesive Patches
7.3.2.1.1 Overview
7.3.2.1.2 Drug-in-Adhesive Patches: Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
7.3.2.2 Matrix Patches
7.3.2.2.1 Overview
7.3.2.2.2 Matrix Patches: Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
7.3.2.3 Reservoir Membrane Patches
7.3.2.3.1 Overview
7.3.2.3.2 Reservoir Membrane Patches: Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
7.3.2.4 Vapor Patches
7.3.2.4.1 Overview
7.3.2.4.2 Vapor Patches: Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
7.4 Transdermal Gels
7.4.1 Overview
7.4.2 Transdermal Gels: Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
7.5 Transdermal Sprays
7.5.1 Overview
7.5.2 Transdermal Sprays: Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
7.6 Others
7.6.1 Overview
7.6.2 Others: Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
8. Global Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 – by Application
8.1 Overview
8.2 Transdermal Drug Delivery System Market Revenue Share, by Application 2022 & 2030 (%)
8.3 Cardiovascular Diseases
8.3.1 Overview
8.3.2 Cardiovascular Diseases: Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
8.4 Central Nervous System Disorders
8.4.1 Overview
8.4.2 Central Nervous System Disorders: Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
8.5 Pain Management
8.5.1 Overview
8.5.2 Pain Management: Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
8.5.2.1 Opioid
8.5.2.1.1 Overview
8.5.2.1.2 Opioid: Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
8.5.2.2 Non-Opioid
8.5.2.2.1 Overview
8.5.2.2.2 Non-Opioid: Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
8.6 Hormonal Applications
8.6.1 Overview
8.6.2 Hormonal Applications: Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
8.6.2.1 Transdermal Estrogen & Progesterone Therapy
8.6.2.1.1 Overview
8.6.2.1.2 Transdermal Estrogen & Progesterone Therapy: Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
8.6.2.2 Testosterone Replacement
8.6.2.2.1 Overview
8.6.2.2.2 Testosterone Replacement: Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
8.7 Other Application
8.7.1 Overview
8.7.2 Other Application: Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
9. Global Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 – by Distribution Channel
9.1 Overview
9.2 Transdermal Drug Delivery System Market Revenue Share, by Distribution Channel 2022 & 2030 (%)
9.3 Hospital Pharmacies
9.3.1 Overview
9.3.2 Hospital Pharmacies: Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
9.4 Retail Pharmacies
9.4.1 Overview
9.4.2 Retail Pharmacies: Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
9.5 Online Pharmacies
9.5.1 Overview
9.5.2 Online Pharmacies: Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
9.6 Others
9.6.1 Overview
9.6.2 Others: Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
10. Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 – Geographic Analysis
10.1 North America: Transdermal Drug Delivery System Market
10.1.1 Overview
10.1.2 North America: Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
10.1.3 North America: Transdermal Drug Delivery System Market, by Product, 2020–2030 (US$ Million)
10.1.3.1 North America: Transdermal Drug Delivery System Market, For Transdermal Patches by Product, 2020–2030 (US$ Million)
10.1.4 North America: Transdermal Drug Delivery System Market, by Application, 2020–2030 (US$ Million)
10.1.4.1 North America: Transdermal Drug Delivery System Market, For Pain Management by Application, 2020–2030 (US$ Million)
10.1.4.2 North America: Transdermal Drug Delivery System Market, For Hormonal Applications by Application, 2020–2030 (US$ Million)
10.1.5 North America: Transdermal Drug Delivery System Market, by Distribution Channel, 2020–2030 (US$ Million)
10.1.5.1 US: Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
10.1.5.1.1 Overview
10.1.5.1.2 US: Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
10.1.5.1.3 US: Transdermal Drug Delivery System Market, by Product, 2020–2030 (US$ Million)
10.1.5.1.3.1 US: Transdermal Drug Delivery System Market, For Transdermal Patches by Product, 2020–2030 (US$ Million)
10.1.5.1.4 US: Transdermal Drug Delivery System Market, by Application, 2020–2030 (US$ Million)
10.1.5.1.4.1 US: Transdermal Drug Delivery System Market, For Pain Management by Application, 2020–2030 (US$ Million)
10.1.5.1.4.2 US: Transdermal Drug Delivery System Market, For Hormonal Applications by Application, 2020–2030 (US$ Million)
10.1.5.1.5 US: Transdermal Drug Delivery System Market, by Distribution Channel, 2020–2030 (US$ Million)
10.1.5.2 Canada: Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
10.1.5.2.1 Overview
10.1.5.2.2 Canada: Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
10.1.5.2.3 Canada: Transdermal Drug Delivery System Market, by Product, 2020–2030 (US$ Million)
10.1.5.2.3.1 Canada: Transdermal Drug Delivery System Market, For Transdermal Patches by Product, 2020–2030 (US$ Million)
10.1.5.2.4 Canada: Transdermal Drug Delivery System Market, by Application, 2020–2030 (US$ Million)
10.1.5.2.4.1 Canada: Transdermal Drug Delivery System Market, For Pain Management by Application, 2020–2030 (US$ Million)
10.1.5.2.4.2 Canada: Transdermal Drug Delivery System Market, For Hormonal Applications by Application, 2020–2030 (US$ Million)
10.1.5.2.5 Canada: Transdermal Drug Delivery System Market, by Distribution Channel, 2020–2030 (US$ Million)
10.1.5.3 Mexico: Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
10.1.5.3.1 Overview
10.1.5.3.2 Mexico: Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
10.1.5.3.3 Mexico: Transdermal Drug Delivery System Market, by Product, 2020–2030 (US$ Million)
10.1.5.3.3.1 Mexico: Transdermal Drug Delivery System Market, For Transdermal Patches by Product, 2020–2030 (US$ Million)
10.1.5.3.4 Mexico: Transdermal Drug Delivery System Market, by Application, 2020–2030 (US$ Million)
10.1.5.3.4.1 Mexico: Transdermal Drug Delivery System Market, For Pain Management by Application, 2020–2030 (US$ Million)
10.1.5.3.4.2 Mexico: Transdermal Drug Delivery System Market, For Hormonal Applications by Application, 2020–2030 (US$ Million)
10.1.5.3.5 Mexico: Transdermal Drug Delivery System Market, by Distribution Channel, 2020–2030 (US$ Million)
10.2 Europe: Transdermal Drug Delivery System Market
10.2.1 Overview
10.2.2 Europe: Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
10.2.3 Europe: Transdermal Drug Delivery System Market, by Product, 2020–2030 (US$ Million)
10.2.3.1 Europe: Transdermal Drug Delivery System Market, For Transdermal Patches by Product, 2020–2030 (US$ Million)
10.2.4 Europe: Transdermal Drug Delivery System Market, by Application, 2020–2030 (US$ Million)
10.2.4.1 Europe: Transdermal Drug Delivery System Market, For Pain Management by Application, 2020–2030 (US$ Million)
10.2.4.2 Europe: Transdermal Drug Delivery System Market, For Hormonal Applications by Application, 2020–2030 (US$ Million)
10.2.5 Europe: Transdermal Drug Delivery System Market, by Distribution Channel, 2020–2030 (US$ Million)
10.2.6 Europe: Transdermal Drug Delivery System Market, by Country, 2022 & 2030 (%)
10.2.6.1 Germany: Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
10.2.6.1.1 Overview
10.2.6.1.2 Germany: Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
10.2.6.1.3 Germany: Transdermal Drug Delivery System Market, by Product, 2020–2030 (US$ Million)
10.2.6.1.3.1 Germany: Transdermal Drug Delivery System Market, For Transdermal Patches by Product, 2020–2030 (US$ Million)
10.2.6.1.4 Germany: Transdermal Drug Delivery System Market, by Application, 2020–2030 (US$ Million)
10.2.6.1.4.1 Germany: Transdermal Drug Delivery System Market, For Pain Management by Application, 2020–2030 (US$ Million)
10.2.6.1.4.2 Germany: Transdermal Drug Delivery System Market, For Hormonal Applications by Application, 2020–2030 (US$ Million)
10.2.6.1.5 Germany: Transdermal Drug Delivery System Market, by Distribution Channel, 2020–2030 (US$ Million)
10.2.6.2 France: Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
10.2.6.2.1 Overview
10.2.6.2.2 France: Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
10.2.6.2.3 France: Transdermal Drug Delivery System Market, by Product, 2020–2030 (US$ Million)
10.2.6.2.3.1 France: Transdermal Drug Delivery System Market, For Transdermal Patches by Product, 2020–2030 (US$ Million)
10.2.6.2.4 France: Transdermal Drug Delivery System Market, by Application, 2020–2030 (US$ Million)
10.2.6.2.4.1 France: Transdermal Drug Delivery System Market, For Pain Management by Application, 2020–2030 (US$ Million)
10.2.6.2.4.2 France: Transdermal Drug Delivery System Market, For Hormonal Applications by Application, 2020–2030 (US$ Million)
10.2.6.2.5 France: Transdermal Drug Delivery System Market, by Distribution Channel, 2020–2030 (US$ Million)
10.2.6.3 UK: Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
10.2.6.3.1 Overview
10.2.6.3.2 UK: Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
10.2.6.3.3 UK: Transdermal Drug Delivery System Market, by Product, 2020–2030 (US$ Million)
10.2.6.3.3.1 UK: Transdermal Drug Delivery System Market, For Transdermal Patches by Product, 2020–2030 (US$ Million)
10.2.6.3.4 UK: Transdermal Drug Delivery System Market, by Application, 2020–2030 (US$ Million)
10.2.6.3.4.1 UK: Transdermal Drug Delivery System Market, For Pain Management by Application, 2020–2030 (US$ Million)
10.2.6.3.4.2 UK: Transdermal Drug Delivery System Market, For Hormonal Applications by Application, 2020–2030 (US$ Million)
10.2.6.3.5 UK: Transdermal Drug Delivery System Market, by Distribution Channel, 2020–2030 (US$ Million)
10.2.6.4 Italy: Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
10.2.6.4.1 Overview
10.2.6.4.2 Italy: Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
10.2.6.4.3 Italy: Transdermal Drug Delivery System Market, by Product, 2020–2030 (US$ Million)
10.2.6.4.3.1 Italy: Transdermal Drug Delivery System Market, For Transdermal Patches by Product, 2020–2030 (US$ Million)
10.2.6.4.4 Italy: Transdermal Drug Delivery System Market, by Application, 2020–2030 (US$ Million)
10.2.6.4.4.1 Italy: Transdermal Drug Delivery System Market, For Pain Management by Application, 2020–2030 (US$ Million)
10.2.6.4.4.2 Italy: Transdermal Drug Delivery System Market, For Hormonal Applications by Application, 2020–2030 (US$ Million)
10.2.6.4.5 Italy: Transdermal Drug Delivery System Market, by Distribution Channel, 2020–2030 (US$ Million)
10.2.6.5 Spain: Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
10.2.6.5.1 Overview
10.2.6.5.2 Spain: Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
10.2.6.5.3 Spain: Transdermal Drug Delivery System Market, by Product, 2020–2030 (US$ Million)
10.2.6.5.3.1 Spain: Transdermal Drug Delivery System Market, For Transdermal Patches by Product, 2020–2030 (US$ Million)
10.2.6.5.4 Spain: Transdermal Drug Delivery System Market, by Application, 2020–2030 (US$ Million)
10.2.6.5.4.1 Spain: Transdermal Drug Delivery System Market, For Pain Management by Application, 2020–2030 (US$ Million)
10.2.6.5.4.2 Spain: Transdermal Drug Delivery System Market, For Hormonal Applications by Application, 2020–2030 (US$ Million)
10.2.6.5.5 Spain: Transdermal Drug Delivery System Market, by Distribution Channel, 2020–2030 (US$ Million)
10.2.6.6 Rest of Europe: Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
10.2.6.6.1 Overview
10.2.6.6.2 Rest of Europe: Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
10.2.6.6.3 Rest of Europe: Transdermal Drug Delivery System Market, by Product, 2020–2030 (US$ Million)
10.2.6.6.3.1 Rest of Europe: Transdermal Drug Delivery System Market, For Transdermal Patches by Product, 2020–2030 (US$ Million)
10.2.6.6.4 Rest of Europe: Transdermal Drug Delivery System Market, by Application, 2020–2030 (US$ Million)
10.2.6.6.4.1 Rest of Europe: Transdermal Drug Delivery System Market, For Pain Management by Application, 2020–2030 (US$ Million)
10.2.6.6.4.2 Rest of Europe: Transdermal Drug Delivery System Market, For Hormonal Applications by Application, 2020–2030 (US$ Million)
10.2.6.6.5 Rest of Europe: Transdermal Drug Delivery System Market, by Distribution Channel, 2020–2030 (US$ Million)
10.3 Asia Pacific: Transdermal Drug Delivery System Market
10.3.1 Overview
10.3.2 Asia Pacific: Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
10.3.3 Asia Pacific: Transdermal Drug Delivery System Market, by Product, 2020–2030 (US$ Million)
10.3.3.1 Asia Pacific: Transdermal Drug Delivery System Market, For Transdermal Patches by Product, 2020–2030 (US$ Million)
10.3.4 Asia Pacific: Transdermal Drug Delivery System Market, by Application, 2020–2030 (US$ Million)
10.3.4.1 Asia Pacific: Transdermal Drug Delivery System Market, For Pain Management by Application, 2020–2030 (US$ Million)
10.3.4.2 Asia Pacific: Transdermal Drug Delivery System Market, For Hormonal Applications by Application, 2020–2030 (US$ Million)
10.3.5 Asia Pacific: Transdermal Drug Delivery System Market, by Distribution Channel, 2020–2030 (US$ Million)
10.3.6 Asia Pacific: Transdermal Drug Delivery System Market, by Country, 2022 & 2030 (%)
10.3.6.1 China: Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
10.3.6.1.1 Overview
10.3.6.1.2 China: Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
10.3.6.1.3 China: Transdermal Drug Delivery System Market, by Product, 2020–2030 (US$ Million)
10.3.6.1.3.1 China: Transdermal Drug Delivery System Market, For Transdermal Patches by Product, 2020–2030 (US$ Million)
10.3.6.1.4 China: Transdermal Drug Delivery System Market, by Application, 2020–2030 (US$ Million)
10.3.6.1.4.1 China: Transdermal Drug Delivery System Market, For Pain Management by Application, 2020–2030 (US$ Million)
10.3.6.1.4.2 China: Transdermal Drug Delivery System Market, For Hormonal Applications by Application, 2020–2030 (US$ Million)
10.3.6.1.5 China: Transdermal Drug Delivery System Market, by Distribution Channel, 2020–2030 (US$ Million)
10.3.6.2 Japan: Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
10.3.6.2.1 Overview
10.3.6.2.2 Japan: Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
10.3.6.2.3 Japan: Transdermal Drug Delivery System Market, by Product, 2020–2030 (US$ Million)
10.3.6.2.3.1 Japan: Transdermal Drug Delivery System Market, For Transdermal Patches by Product, 2020–2030 (US$ Million)
10.3.6.2.4 Japan: Transdermal Drug Delivery System Market, by Application, 2020–2030 (US$ Million)
10.3.6.2.4.1 Japan: Transdermal Drug Delivery System Market, For Pain Management by Application, 2020–2030 (US$ Million)
10.3.6.2.4.2 Japan: Transdermal Drug Delivery System Market, For Hormonal Applications by Application, 2020–2030 (US$ Million)
10.3.6.2.5 Japan: Transdermal Drug Delivery System Market, by Distribution Channel, 2020–2030 (US$ Million)
10.3.6.3 India: Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
10.3.6.3.1 Overview
10.3.6.3.2 India: Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
10.3.6.3.3 India: Transdermal Drug Delivery System Market, by Product, 2020–2030 (US$ Million)
10.3.6.3.3.1 India: Transdermal Drug Delivery System Market, For Transdermal Patches by Product, 2020–2030 (US$ Million)
10.3.6.3.4 India: Transdermal Drug Delivery System Market, by Application, 2020–2030 (US$ Million)
10.3.6.3.4.1 India: Transdermal Drug Delivery System Market, For Pain Management by Application, 2020–2030 (US$ Million)
10.3.6.3.4.2 India: Transdermal Drug Delivery System Market, For Hormonal Applications by Application, 2020–2030 (US$ Million)
10.3.6.3.5 India: Transdermal Drug Delivery System Market, by Distribution Channel, 2020–2030 (US$ Million)
10.3.6.4 Australia: Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
10.3.6.4.1 Overview
10.3.6.4.2 Australia: Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
10.3.6.4.3 Australia: Transdermal Drug Delivery System Market, by Product, 2020–2030 (US$ Million)
10.3.6.4.3.1 Australia: Transdermal Drug Delivery System Market, For Transdermal Patches by Product, 2020–2030 (US$ Million)
10.3.6.4.4 Australia: Transdermal Drug Delivery System Market, by Application, 2020–2030 (US$ Million)
10.3.6.4.4.1 Australia: Transdermal Drug Delivery System Market, For Pain Management by Application, 2020–2030 (US$ Million)
10.3.6.4.4.2 Australia: Transdermal Drug Delivery System Market, For Hormonal Applications by Application, 2020–2030 (US$ Million)
10.3.6.4.5 Australia: Transdermal Drug Delivery System Market, by Distribution Channel, 2020–2030 (US$ Million)
10.3.6.5 South Korea: Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
10.3.6.5.1 Overview
10.3.6.5.2 South Korea: Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
10.3.6.5.3 South Korea: Transdermal Drug Delivery System Market, by Product, 2020–2030 (US$ Million)
10.3.6.5.3.1 South Korea: Transdermal Drug Delivery System Market, For Transdermal Patches by Product, 2020–2030 (US$ Million)
10.3.6.5.4 South Korea: Transdermal Drug Delivery System Market, by Application, 2020–2030 (US$ Million)
10.3.6.5.4.1 South Korea: Transdermal Drug Delivery System Market, For Pain Management by Application, 2020–2030 (US$ Million)
10.3.6.5.4.2 South Korea: Transdermal Drug Delivery System Market, For Hormonal Applications by Application, 2020–2030 (US$ Million)
10.3.6.5.5 South Korea: Transdermal Drug Delivery System Market, by Distribution Channel, 2020–2030 (US$ Million)
10.3.6.6 Rest of Asia Pacific: Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
10.3.6.6.1 Overview
10.3.6.6.2 Rest of Asia Pacific: Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
10.3.6.6.3 Rest of Asia Pacific: Transdermal Drug Delivery System Market, by Product, 2020–2030 (US$ Million)
10.3.6.6.3.1 Rest of Asia Pacific: Transdermal Drug Delivery System Market, For Transdermal Patches by Product, 2020–2030 (US$ Million)
10.3.6.6.4 Rest of Asia Pacific: Transdermal Drug Delivery System Market, by Application, 2020–2030 (US$ Million)
10.3.6.6.4.1 Rest of Asia Pacific: Transdermal Drug Delivery System Market, For Pain Management by Application, 2020–2030 (US$ Million)
10.3.6.6.4.2 Rest of Asia Pacific: Transdermal Drug Delivery System Market, For Hormonal Applications by Application, 2020–2030 (US$ Million)
10.3.6.6.5 Rest of Asia Pacific: Transdermal Drug Delivery System Market, by Distribution Channel, 2020–2030 (US$ Million)
10.4 Middle East & Africa Transdermal Drug Delivery System Market
10.4.1 Overview
10.4.2 Middle East & Africa: Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
10.4.3 Middle East & Africa: Transdermal Drug Delivery System Market, by Product, 2020–2030 (US$ Million)
10.4.3.1 Middle East & Africa: Transdermal Drug Delivery System Market, For Transdermal Patches by Product, 2020–2030 (US$ Million)
10.4.4 Middle East & Africa: Transdermal Drug Delivery System Market, by Application, 2020–2030 (US$ Million)
10.4.4.1 Middle East & Africa: Transdermal Drug Delivery System Market, For Pain Management by Application, 2020–2030 (US$ Million)
10.4.4.2 Middle East & Africa: Transdermal Drug Delivery System Market, For Hormonal Applications by Application, 2020–2030 (US$ Million)
10.4.5 Middle East & Africa: Transdermal Drug Delivery System Market, by Distribution Channel, 2020–2030 (US$ Million)
10.4.5.1 South Africa: Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
10.4.5.1.1 Overview
10.4.5.1.2 South Africa: Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
10.4.5.1.3 South Africa: Transdermal Drug Delivery System Market, by Product, 2020–2030 (US$ Million)
10.4.5.1.3.1 South Africa: Transdermal Drug Delivery System Market, For Transdermal Patches by Product, 2020–2030 (US$ Million)
10.4.5.1.4 South Africa: Transdermal Drug Delivery System Market, by Application, 2020–2030 (US$ Million)
10.4.5.1.4.1 South Africa: Transdermal Drug Delivery System Market, For Pain Management by Application, 2020–2030 (US$ Million)
10.4.5.1.4.2 South Africa: Transdermal Drug Delivery System Market, For Hormonal Applications by Application, 2020–2030 (US$ Million)
10.4.5.1.5 South Africa: Transdermal Drug Delivery System Market, by Distribution Channel, 2020–2030 (US$ Million)
10.4.5.2 Saudi Arabia: Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
10.4.5.2.1 Overview
10.4.5.2.2 Saudi Arabia: Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
10.4.5.2.3 Saudi Arabia: Transdermal Drug Delivery System Market, by Product, 2020–2030 (US$ Million)
10.4.5.2.3.1 Saudi Arabia: Transdermal Drug Delivery System Market, For Transdermal Patches by Product, 2020–2030 (US$ Million)
10.4.5.2.4 Saudi Arabia: Transdermal Drug Delivery System Market, by Application, 2020–2030 (US$ Million)
10.4.5.2.4.1 Saudi Arabia: Transdermal Drug Delivery System Market, For Pain Management by Application, 2020–2030 (US$ Million)
10.4.5.2.4.2 Saudi Arabia: Transdermal Drug Delivery System Market, For Hormonal Applications by Application, 2020–2030 (US$ Million)
10.4.5.2.5 Saudi Arabia: Transdermal Drug Delivery System Market, by Distribution Channel, 2020–2030 (US$ Million)
10.4.5.3 UAE: Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
10.4.5.3.1 Overview
10.4.5.3.2 UAE: Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
10.4.5.3.3 UAE: Transdermal Drug Delivery System Market, by Product, 2020–2030 (US$ Million)
10.4.5.3.3.1 UAE: Transdermal Drug Delivery System Market, For Transdermal Patches by Product, 2020–2030 (US$ Million)
10.4.5.3.4 UAE: Transdermal Drug Delivery System Market, by Application, 2020–2030 (US$ Million)
10.4.5.3.4.1 UAE: Transdermal Drug Delivery System Market, For Pain Management by Application, 2020–2030 (US$ Million)
10.4.5.3.4.2 UAE: Transdermal Drug Delivery System Market, For Hormonal Applications by Application, 2020–2030 (US$ Million)
10.4.5.3.5 UAE: Transdermal Drug Delivery System Market, by Distribution Channel, 2020–2030 (US$ Million)
10.4.5.4 Rest of Middle East & Africa: Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
10.4.5.4.1 Overview
10.4.5.4.2 Rest of Middle East & Africa: Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
10.4.5.4.3 Rest of Middle East & Africa: Transdermal Drug Delivery System Market, by Product, 2020–2030 (US$ Million)
10.4.5.4.3.1 Rest of Middle East & Africa: Transdermal Drug Delivery System Market, For Transdermal Patches by Product, 2020–2030 (US$ Million)
10.4.5.4.4 Rest of Middle East & Africa: Transdermal Drug Delivery System Market, by Application, 2020–2030 (US$ Million)
10.4.5.4.4.1 Rest of Middle East & Africa: Transdermal Drug Delivery System Market, For Pain Management by Application, 2020–2030 (US$ Million)
10.4.5.4.4.2 Rest of Middle East & Africa: Transdermal Drug Delivery System Market, For Hormonal Applications by Application, 2020–2030 (US$ Million)
10.4.5.4.5 Rest of Middle East & Africa: Transdermal Drug Delivery System Market, by Distribution Channel, 2020–2030 (US$ Million)
10.5 South & Central America: Transdermal Drug Delivery System Market
10.5.1 Overview
10.5.2 South & Central America: Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
10.5.3 South & Central America: Transdermal Drug Delivery System Market, by Product, 2020–2030 (US$ Million)
10.5.3.1 South & Central America: Transdermal Drug Delivery System Market, For Transdermal Patches by Product, 2020–2030 (US$ Million)
10.5.4 South & Central America: Transdermal Drug Delivery System Market, By Application, 2020–2030 (US$ Million)
10.5.4.1 South & Central America: Transdermal Drug Delivery System Market, For Pain Management by Application, 2020–2030 (US$ Million)
10.5.4.2 South & Central America: Transdermal Drug Delivery System Market, For Hormonal Applications by Application, 2020–2030 (US$ Million)
10.5.5 South & Central America: Transdermal Drug Delivery System Market, By Distribution Channel, 2020–2030 (US$ Million)
10.5.6 South & Central America: Transdermal Drug Delivery System Market Share by Country – 2022 & 2030, (%)
10.5.6.1 Brazil: Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
10.5.6.1.1 Overview
10.5.6.2 Brazil: Transdermal Drug Delivery System Market- Revenue and Forecasts to 2030 (US$ Million)
10.5.6.2.1 Brazil: Transdermal Drug Delivery System Market, by Product, 2020–2030 (US$ Million)
10.5.6.2.1.1 Brazil: Transdermal Drug Delivery System Market, For Transdermal Patches by Product, 2020–2030 (US$ Million)
10.5.6.2.2 Brazil: Transdermal Drug Delivery System Market, by Application, 2020–2030 (US$ Million)
10.5.6.2.2.1 Brazil: Transdermal Drug Delivery System Market, For Pain Management by Application, 2020–2030 (US$ Million)
10.5.6.2.2.2 Brazil: Transdermal Drug Delivery System Market, For Hormonal Applications by Application, 2020–2030 (US$ Million)
10.5.6.2.3 Brazil: Transdermal Drug Delivery System Market, by Distribution Channel, 2020–2030 (US$ Million)
10.5.6.3 Argentina: Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
10.5.6.3.1 Overview
10.5.6.4 Argentina: Transdermal Drug Delivery System Market- Revenue and Forecasts to 2030 (US$ Million)
10.5.6.4.1 Argentina: Transdermal Drug Delivery System Market, by Product, 2020–2030 (US$ Million)
10.5.6.4.1.1 Argentina: Transdermal Drug Delivery System Market, For Transdermal Patches by Product, 2020–2030 (US$ Million)
10.5.6.4.2 Argentina: Transdermal Drug Delivery System Market, by Application, 2020–2030 (US$ Million)
10.5.6.4.2.1 Argentina: Transdermal Drug Delivery System Market, For Pain Management by Application, 2020–2030 (US$ Million)
10.5.6.4.2.2 Argentina: Transdermal Drug Delivery System Market, For Hormonal Applications by Application, 2020–2030 (US$ Million)
10.5.6.4.3 Argentina: Transdermal Drug Delivery System Market, by Distribution Channel, 2020–2030 (US$ Million)
10.5.6.5 Rest of South & Central America: Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
10.5.6.5.1 Overview
10.5.6.6 Rest of South & Central America: Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
10.5.6.6.1 Rest of South & Central America: Transdermal Drug Delivery System Market, by Product, 2020–2030 (US$ Million)
10.5.6.6.1.1 Rest of South & Central America: Transdermal Drug Delivery System Market, For Transdermal Patches by Product, 2020–2030 (US$ Million)
10.5.6.6.2 Rest of South & Central America: Transdermal Drug Delivery System Market, by Application, 2020–2030 (US$ Million)
10.5.6.6.2.1 Rest of South & Central America: Transdermal Drug Delivery System Market, For Pain Management by Application, 2020–2030 (US$ Million)
10.5.6.6.2.2 Rest of South & Central America: Transdermal Drug Delivery System Market, For Hormonal Applications by Application, 2020–2030 (US$ Million)
10.5.6.6.3 Rest of South & Central America: Transdermal Drug Delivery System Market, by Distribution Channel, 2020–2030 (US$ Million)
11. Transdermal Drug Delivery System Market Industry Landscape
11.1 Overview
11.2 Growth Strategies in the Transdermal Drug Delivery System Market
11.3 Inorganic Growth Strategies
11.3.1 Overview
11.4 Organic Growth Strategies
11.4.1 Overview
12. Company Profiles
12.1 Novartis AG
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Johnson & Johnson
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 GSK Plc
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Viatris Inc
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Boehringer Ingelheim International GmbH
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Hisamitsu Pharmaceutical Co Inc
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 Luye Pharma Group Ltd
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 Lavipharm SA
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
12.9 Purdue Pharma LP
12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Products and Services
12.9.4 Financial Overview
12.9.5 SWOT Analysis
12.9.6 Key Developments
12.10 UCB SA
12.10.1 Key Facts
12.10.2 Business Description
12.10.3 Products and Services
12.10.4 Financial Overview
12.10.5 SWOT Analysis
12.10.6 Key Developments
13. Appendix
13.1 About Us
13.2 Glossary of Terms

　

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野（医療機器）の最新刊レポート

The Insight Partners社の医療機器分野での最新刊レポート

本レポートと同じKEY WORD（drug）の最新刊レポート


よくあるご質問


The Insight Partners社はどのような調査会社ですか?


The Insight Partnersはインドに本社を置く調査会社です。経験豊富な専門家チームを通じて、お客様に最適な調査と分析を提供することに専念しています。幅広い分野をカバーしていますがヘルスケ... もっと見る


調査レポートの納品までの日数はどの程度ですか?


在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。


注文の手続きはどのようになっていますか?


1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。


お支払方法の方法はどのようになっていますか?


納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
お客様よりデータリソース社へ（通常は円払い）の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。


データリソース社はどのような会社ですか?


当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。



詳細検索

このレポートへのお問合せ

お問合せはこちらから

03-3582-2531

電話お問合せもお気軽に

 

2024/11/22　10:26

155.52 円

163.34 円

198.56 円

ページTOPに戻る

株式会社 データリソース　Data Resources, Inc.
東京都港区赤坂1-14-5　アークヒルズエグゼクティブタワー N313

電話：03-3582-2531
FAX：03-3582-2861
Eメール：office@dri.co.jp

FAQ サイトマップ プライバシーポリシー お問合せ

関連会社:
株式会社ユーディーアール

COPYRIGHT(C) 2011-2023　DATA RESOURCES, Inc. ALL RIGHTS RESERVED.